Bioactive phenolate ionic complexes
AssigneesYissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services and Development Ltd.
InventorsAbraham Jacob DOMB, Noam STEINMAN, Yakir ROTTENBERG
Life of this patent
Estimating the term…
Abstract
The invention provides an isolated material, or a phenolate form of at least one phenol- containing active material, wherein the isolated material comprises one or more phenolate species and a counter ion (a cation) in the form of a metal salt, a phosphonium or an ammonium.
Claims20
1-85. (canceled)
An isolated material comprising at least one phenol-containing active material and a metal salt, a phosphonium or an ammonium salt counter-ion, wherein the active material is not phenol (C6H6O), methylphenol, bromophenol, dibromophenol, tribromophenol, pentachlorophenol, bisphenol A, tetrabromobisphenol A, resorcinol, hydroquinone, hydroquinone or naphthol.
A material comprising at least one cannabinoid in a form of a phenolate and a cation selected from metal cations, phosphonium and ammonium.
A calcium CBD salt comprising one CDB and optionally another non-cannabinoid or two CBDs.
A material being a cholate salt of at least one phenol active material.
A composition or a formulation comprising a material, wherein the material comprising an ammonium cation or a poly-ammonium, and at least one active material comprising at least one phenolate moiety ionically bonded to the ammonium or the poly-ammonium cation, wherein the composition or the formulation is for use in treating a disease or disorder which is treatable by administering to a subject a therapeutically effective amount of the composition or the formulation.
Dependencies are inferred from the claim text.